We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1B
AUM Growth
+$81M
Cap. Flow
+$45.6M
Cap. Flow %
4.55%
Top 10 Hldgs %
62.52%
Holding
4,698
New
814
Increased
789
Reduced
1,481
Closed
1,566

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$213M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$157M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$63.3M
4
UWM icon
ProShares Ultra Russell2000
UWM
+$20.4M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$19.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
MSFT icon
Microsoft
MSFT
+$11.7M
3
XOM icon
ExxonMobil
XOM
+$10.9M
4
BAC icon
Bank of America
BAC
+$8.84M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.82M

Sector Composition

Rank Sector Weight
1 Financials 1.65%
2 Technology 1.48%
3 Materials 1.36%
4 Healthcare 1.28%
5 Industrials 1.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBIV
2876
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$1K ﹤0.01%
7
-13
-65% -$1.76K
AAU
2877
DELISTED
Almaden Minerals Ltd
AAU
$1K ﹤0.01%
400
-1,300
-76% -$1.41K
MARK
2878
DELISTED
Remark Holdings, Inc.
MARK
$1K ﹤0.01%
+31
New +$979
FRTX
2879
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1K ﹤0.01%
+1
New +$705
LTRPB
2880
DELISTED
Liberty TripAdvisor Holdings, Inc. Series B
LTRPB
$1K ﹤0.01%
+106
New +$1.56K
SVVC
2881
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$1K ﹤0.01%
68
-163
-71% -$1.31K
KDNY
2882
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
20
-133
-87% -$7.51K
NMTR
2883
DELISTED
9 Meters Biopharma
NMTR
$1K ﹤0.01%
3
+1
+50% +$300
HVBC
2884
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
$1K ﹤0.01%
+100
New +$1.4K
BLCM
2885
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1K ﹤0.01%
10
-530
-98% -$69.4K
CLR
2886
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1K ﹤0.01%
20
-3,812
-99% -$180K
HLG
2887
DELISTED
Hailiang Education Group Inc. American Depositary Shares
HLG
$1K ﹤0.01%
+81
New +$687
GSV
2888
DELISTED
Gold Standard Ventures Corp.
GSV
$1K ﹤0.01%
+200
New +$507
HSTO
2889
DELISTED
Histogen Inc. Common Stock
HSTO
$1K ﹤0.01%
+1
New +$965
PTE
2890
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1K ﹤0.01%
4
– –
FOE
2891
DELISTED
Ferro Corporation
FOE
$1K ﹤0.01%
50
-2,155
-98% -$30.9K
LMRK
2892
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$1K ﹤0.01%
100
-527
-84% -$8.09K
IFMK
2893
DELISTED
iFresh Inc. Common Stock
IFMK
$1K ﹤0.01%
+76
New +$1.33K
TRIL
2894
DELISTED
Trillium Therapeutics Inc.
TRIL
$1K ﹤0.01%
100
-200
-67% -$1.17K
XONE
2895
DELISTED
The ExOne Company
XONE
$1K ﹤0.01%
100
-1,836
-95% -$18.5K
QADB
2896
DELISTED
QAD Inc. Class B
QADB
$1K ﹤0.01%
50
-116
-70% -$2.84K
SLCT
2897
DELISTED
Select Bancorp, Inc.
SLCT
$1K ﹤0.01%
112
-1,252
-92% -$13.3K
MFNC
2898
DELISTED
Mackinac Financial Corporation
MFNC
$1K ﹤0.01%
+50
New +$670
SHSP
2899
DELISTED
SharpSpring, Inc.
SHSP
$1K ﹤0.01%
+144
New +$735
GNMK
2900
DELISTED
GenMark Diagnostics, Inc
GNMK
$1K ﹤0.01%
100
-2,926
-97% -$35.2K
114 115
116
117 118

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2017 Portfolio in Review

As of Q1 2017, Tower Research Capital (TRC) held 4,698 positions worth $1B, up 8.8% from $921M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tower Research Capital (TRC) deployed $45.6M of net new capital in Q1 2017, opening 814 new positions and adding to 789 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 14% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Apple, an estimated $13.3M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2017 buy was ProShares Ultra Russell2000: 717,004 shares worth $20.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $213M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2017 reduction was Apple, cutting an estimated $13.3M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2017, selling an estimated $8.82M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 63% of its $1B portfolio in Q1 2017.
  • Tower Research Capital (TRC) opened 814 new positions and closed 1,566 in Q1 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 8.8% quarter-over-quarter to $1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.